Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BRISTOL MYERS SQUIBB CO | 196,156 | reported | 02 Mar 2004 | tx 4+178,333−5,127 |
| INSMED Inc | 62,197 | reported | 09 Apr 2019 | tx 43+375,100.5−221,109 |
| REGENXBIO Inc. | 10,000 | reported | 29 May 2020 | tx 58+335,682−527,198 |
| AMICUS THERAPEUTICS, INC. | 8,895 | reported | 07 Jun 2018 | tx 24+304,043−150,000 |
| Theseus Pharmaceuticals, Inc. | 0 | reported | 14 Feb 2024 | tx 7+92,750−13,250 |
| Vitae Pharmaceuticals, Inc | 0 | reported | 25 Oct 2016 | tx 21+105,390−191,962 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Feb 2024 | TENDER | Theseus Pharmaceuticals, Inc. | 10,000 | — | |
| 14 Feb 2024 | OTHER | Theseus Pharmaceuticals, Inc. | 3,250 | — | deriv |
| 13 Jun 2023 | GRANT_AWARD | Theseus Pharmaceuticals, Inc. | 19,500 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Theseus Pharmaceuticals, Inc. | 3,250 | 0.00 USD | deriv |
| 29 Dec 2022 | PURCHASE | Theseus Pharmaceuticals, Inc. | 100 | 5.00 USD | first after silence |
| 30 Dec 2022 | PURCHASE | Theseus Pharmaceuticals, Inc. | 9,900 | 5.00 USD | |
| 17 May 2022 | GRANT_AWARD | Theseus Pharmaceuticals, Inc. | 60,000 | 0.00 USD | deriv |
| 29 May 2020 | GRANT_AWARD | REGENXBIO Inc. | 10,000 | 0.00 USD | deriv |
| 10 Feb 2020 | SALE | REGENXBIO Inc. | 24,800 | 50.11 USD | |
| 10 Feb 2020 | EXERCISE | REGENXBIO Inc. | 24,800 | 0.85 USD | |
| 10 Feb 2020 | EXERCISE | REGENXBIO Inc. | 24,800 | 0.00 USD | deriv |
| 05 Feb 2020 | EXERCISE | REGENXBIO Inc. | 2,000 | 0.85 USD | |
| 05 Feb 2020 | SALE | REGENXBIO Inc. | 2,000 | 50.00 USD | |
| 05 Feb 2020 | EXERCISE | REGENXBIO Inc. | 2,000 | 0.00 USD | deriv |
| 17 Jan 2020 | SALE | REGENXBIO Inc. | 3,200 | 50.01 USD | |
| 17 Jan 2020 | EXERCISE | REGENXBIO Inc. | 3,200 | 0.85 USD | |
| 17 Jan 2020 | EXERCISE | REGENXBIO Inc. | 3,200 | 0.00 USD | deriv |
| 14 Jan 2020 | EXERCISE | REGENXBIO Inc. | 30,000 | 0.85 USD | |
| 14 Jan 2020 | SALE | REGENXBIO Inc. | 30,000 | 45.60 USD | |
| 14 Jan 2020 | EXERCISE | REGENXBIO Inc. | 30,000 | 0.00 USD | deriv |
| 31 May 2019 | GRANT_AWARD | REGENXBIO Inc. | 10,000 | 0.00 USD | deriv |
| 09 Apr 2019 | SALE | INSMED Inc | 6,286 | 32.99 USD | |
| 09 Apr 2019 | EXERCISE | INSMED Inc | 6,286 | 3.03 USD | |
| 09 Apr 2019 | EXERCISE | INSMED Inc | 6,286 | 0.00 USD | deriv |
| 15 Feb 2019 | EXERCISE | INSMED Inc | 100 | 3.03 USD |
1 purchase reported after at least 12 months of silence — most recent on 29 Dec 2022.